Solomon, James A.
Mayo Clinic
Ameriderm Research, Ormond Beach, FL
Citations 3
Vismodegib in the treatment of patients with metastatic basal cell carcinoma (mBCC) and distant metastases: Survival in the pivotal phase II and phase I studies.
Lewis, Karl D. , Sekulić, Aleksandar , Migden, Michael R. , Oro, Anthony E. , LoRusso, Patricia , Hainsworth, John D. , Williams, Sarah, Hou, Jeannie , Hoff, Daniel D. Von , Hauschild, Axel , Rudin, Charles M. , Dirix, Luc , Solomon, James A.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 9012-9012
Chromosome 9 mutations reported absent in some patients with basal cell carcinoma nevus syndrome
Shih, Shawn , Urso, Brittany , Domozych, Renee, Updyke, Katelyn Mariko , Laughlin, Amy Iarrobino , Solomon, James A.
Journal of the European Academy of Dermatology and Venereology | November 14, 2017 | Volume: 32 | Issue: 5 | Pages: No page available
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma
Chang, Anne Lynn S. , Lewis, Karl D. , Arron, Sarah T. , Migden, Michael R. , Yoo, Simon , Day, Bann‐Mo, McKenna, Edward , Sekulić, Aleksandar , Solomon, James A.
Oncotarget | October 14, 2016 | Volume: 7 | Issue: 46 | Pages: 76118-76124